share_log

Strong Week for Ji Yao Holding Group (SZSE:300108) Shareholders Doesn't Alleviate Pain of Five-year Loss

Strong Week for Ji Yao Holding Group (SZSE:300108) Shareholders Doesn't Alleviate Pain of Five-year Loss

st吉藥控股集團(SZSE:300108)股東度過強勁的一週,並不能減輕五年來的虧損之痛
Simply Wall St ·  11/04 15:12

Over the last month the Ji Yao Holding Group Co., Ltd. (SZSE:300108) has been much stronger than before, rebounding by 32%. But that doesn't change the fact that the returns over the last five years have been less than pleasing. After all, the share price is down 24% in that time, significantly under-performing the market.

在過去的一個月裏,st吉藥集團股份有限公司(SZSE:300108)比以往任何時候都要強大得多,反彈了32%。 但這並不改變過去五年的回報令人不滿的事實。 畢竟,股價在那個時期下跌了24%,明顯低於市場表現。

On a more encouraging note the company has added CN¥360m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

更令人鼓舞的是,公司在過去7天內市值增加了36000萬人民幣,讓我們看看是什麼推動了股東五年的損失。

Because Ji Yao Holding Group made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally hope to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

因爲st吉藥集團在過去十二個月中虧損,我們認爲市場可能更專注於營業收入和營業收入增長,至少目前是這樣。 當一家公司沒有利潤時,我們通常希望看到良好的營業收入增長。 你可以想象,快速的營業收入增長,如果能保持,通常會導致快速的利潤增長。

Over half a decade Ji Yao Holding Group reduced its trailing twelve month revenue by 23% for each year. That puts it in an unattractive cohort, to put it mildly. On the face of it we'd posit the share price fall of 4% compound, over five years is well justified by the fundamental deterioration. We doubt many shareholders are delighted with this share price performance. It is possible for businesses to bounce back but as Buffett says, 'turnarounds seldom turn'.

在半個多世紀的時間裏,st吉藥集團每年的滾動十二個月營業收入下降了23%。 這使其成爲一個不太吸引人的隊伍,委婉地說。 從表面上看,我們認爲,在過去五年裏,股價下跌了4%,這在根本上是合理的。 我們懷疑很多股東對這種股價表現感到高興。 企業有可能東山再起,但正如巴菲特所說,「轉機很少有轉機」。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下方圖片中看到盈利和營業收入隨時間的變化(單擊圖表查看準確數值)。

big
SZSE:300108 Earnings and Revenue Growth November 4th 2024
SZSE:300108 2024年11月4日盈利和營業收入增長

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

你可以在這個免費的互動圖表中看到它的資產負債表如何隨着時間的推移而加強(或削弱)。

A Different Perspective

另一種看法

Investors in Ji Yao Holding Group had a tough year, with a total loss of 8.1%, against a market gain of about 5.2%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 4% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 3 warning signs for Ji Yao Holding Group you should be aware of.

吉藥控股集團的投資者經歷了艱難的一年,整體虧損了8.1%,而市場收益約爲5.2%。然而,請記住,即使是最好的股票有時也會在十二個月的期間表現不佳。遺憾的是,去年的表現爲一段糟糕的運行畫上了句號,股東們在過去五年中每年面臨着4%的總虧損。我們意識到,羅斯柴爾德男爵曾說投資者應該在「街上血流成河」的時候買入,但我們警告投資者應首先確保他們購買的是高質量的業務。我發現長期觀察股價作爲業績的替代方案非常有意思。但要真正獲得見解,我們需要考慮其他信息。例如:我們發現了吉藥控股集團的3個警示信號,您應該注意。

We will like Ji Yao Holding Group better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.

如果我們看到一些大規模內部人士的買入行爲,我們將更喜歡吉藥控股集團。在等待期間,請查看這份免費的被低估的股票名單(主要是小市值股票),其中包括可觀的最近內部人員購買。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文中引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論